STRUCTURES OF METABOLITES ISOLATED FROM URINE OF MICE TREATED WITH THE ANTIVIRAL AGENT, 1-(2-FLUORO-2-DEOXY-BETA-D-ARABINOFURANOSYL)-5-METHYLURACIL

被引：0
|
作者：
FEINBERG, A
VIDAL, PM
FOX, JJ
WATANABE, KA
CHUN, MW
FIELD, FH
BENCSATH, A
CHAIT, B
PHILIPS, FS
机构：
[1] MEM SLOAN KETTERING CANC CTR,ORGAN CHEM LAB,NEW YORK,NY 10021
[2] ROCKEFELLER UNIV,NEW YORK,NY 10021
来源：
DRUG METABOLISM AND DISPOSITION | 1984年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：784 / 786
页数：3
相关论文
共 50 条
  • [1] DISTRIBUTION, METABOLISM, AND EXCRETION OF 1-(2-FLUORO-2-DEOXY-BETA-D-ARABINOFURANOSYL)THYMINE AND 1-(2-FLUORO-2-DEOXY-BETA-D-ARABINOFURANOSYL)-5-IODOCYTOSINE
    PHILIPS, FS
    FEINBERG, A
    CHOU, TC
    VIDAL, PM
    SU, TL
    WATANABE, KA
    FOX, JJ
    CANCER RESEARCH, 1983, 43 (08) : 3619 - 3627
  • [2] ABINITIO STUDIES OF THE ANTIVIRAL DRUG 1-(2-FLUORO-2-DEOXY-BETA-D-ARABINOFURANOSYL) THYMINE
    SAPSE, AM
    SNYDER, G
    CANCER INVESTIGATION, 1985, 3 (02) : 115 - 121
  • [3] FLUORO CARBOCYCLIC NUCLEOSIDES - SYNTHESIS AND ANTIVIRAL ACTIVITY OF 2'-FLUORO AND 6'-FLUORO CARBOCYCLIC PYRIMIDINE NUCLEOSIDES INCLUDING CARBOCYCLIC 1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-METHYLURACIL AND CARBOCYCLIC 1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOURACIL
    BORTHWICK, AD
    EVANS, DN
    KIRK, BE
    BIGGADIKE, K
    EXALL, AM
    YOUDS, P
    ROBERTS, SM
    KNIGHT, DJ
    COATES, JAV
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) : 179 - 186
  • [4] PHASE-I TRIAL OF 1-(2'-DEOXY-2'-FLUORO-1-BETA-D-ARABINOFURANOSYL)-5-METHYLURACIL (FMAU)
    FANUCCHI, MP
    LEYLANDJONES, B
    YOUNG, CW
    BURCHENAL, JH
    WATANABE, KA
    FOX, JJ
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 55 - 59
  • [5] HUMAN CYTOMEGALOVIRUS-INDUCED DNA-POLYMERASE AND ITS INTERACTION WITH THE TRIPHOSPHATES OF 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-METHYLURACIL, 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOCYTOSINE, AND 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-METHYLCYTOSINE
    MAR, EC
    CHIOU, JF
    CHENG, YC
    HUANG, ES
    JOURNAL OF VIROLOGY, 1985, 56 (03) : 846 - 851
  • [6] PHASE-I TRIAL OF 1-(2'-DEOXY-2'-FLUORO-1-BETA-D-ARABINOFURANOSYL)-5-METHYLURACIL (FMAU) TERMINATED BY SEVERE NEUROLOGIC TOXICITY
    ABBRUZZESE, JL
    SCHMIDT, S
    RABER, MN
    LEVY, JK
    CASTELLANOS, AM
    LEGHA, SS
    KRAKOFF, IH
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 195 - 201
  • [7] Simultaneous determination of 1-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry
    Wiegand, Richard
    Wu, Jianmei
    Shields, Anthony F.
    LoRusso, Patricia
    Li, Jing
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 891 : 64 - 70
  • [8] PHARMACOKINETICS OF 1-(2-DEOXY-2-FLUORO-BETA-1-ARABINO-FURANOSYL)-5-METHYLURACIL (L-FMAU) IN RATS
    WRIGHT, JD
    MA, TW
    CHU, CK
    BOUDINOT, FD
    PHARMACEUTICAL RESEARCH, 1995, 12 (09) : 1350 - 1353
  • [9] SYNTHESIS AND ANTIVIRAL ACTIVITY OF PHOSPHOLIPID DERIVATIVES OF 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOURACIL (FIAU) AND 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOCYTIDINE (FIAC)
    STUHMILLER, LM
    HOSTETLER, KY
    KING, DH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 133 - MEDI
  • [10] DERIVATIVES OF 1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-PHENYLURACIL AND 1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-BENZYLURACIL - SYNTHESIS AND SOME BIOLOGICAL PROPERTIES
    DZIEWISZEK, K
    SU, TL
    WATANABE, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 136 - MEDI
12345